Crosstalk Between MicroRNAs and Peroxisome Proliferator-Activated Receptors and Their Emerging Regulatory Roles in Cardiovascular Pathophysiology

PPAR Research - Egypt
doi 10.1155/2018/8530371
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Crosstalk Between Peroxisome Proliferator-Activated Receptor and VEGF Stimulates Cancer Progression

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Emerging Role of the Peroxisome Proliferator-Activated Receptors in Hepatocellular Carcinoma

Journal of Carcinogenesis & Mutagenesis
2014English

Drugs and the Peroxisome Proliferator Activated Receptors

2014English

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus

Therapeutic Advances in Gastroenterology
Gastroenterology
2011English

Peroxisome Proliferator-Activated Receptors (Ppars) in Health and Disease.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2002English

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection

PPAR Research
Drug DiscoveryPharmacology
2009English

Peroxisome Proliferator-Activated Receptors in Atherosclerosis and Inflammation—An Update

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2001English

Peroxisome Proliferator-Activated Receptor (PPAR) Gamma in Cardiovascular Disorders and Cardiovascular Surgery

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma

PPAR Research
Drug DiscoveryPharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy